Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

ASCOT hype continues

The British Medical Journal this week carries an editorial on the recently published ASCOT Study.

This trial has received a lot of media attention from organisations such as the BBC.

The editorial is factually correct but perhaps it goes a little too far in attempting to second guess the reaction of the National Institute of Clinical Excellence and the British Hypertension Society as they revise their advice.

Continuing the hype around this study the editorial also quotes relative risk reductions that the original paper admit are derived from "fairly small absolute benefits". Adding to the concern is the declaration of competing interests by two of the three authors who appear to work closely with drug companies who are active in the hypertension and diabetes market.

Action: Prescribers should reassure patients about their treatment until the National Guidelines are reviewed and published. Changing practice at this early stage is premature and may mean it needs to be re-changed at a later date.

Share 'ASCOT hype continues' on Email Share 'ASCOT hype continues' on Delicious Share 'ASCOT hype continues' on Digg Share 'ASCOT hype continues' on Facebook Share 'ASCOT hype continues' on Google+ Share 'ASCOT hype continues' on reddit Share 'ASCOT hype continues' on StumbleUpon Share 'ASCOT hype continues' on Twitter

atomic-wealth

No Comments to “ASCOT hype continues”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,429 spam comments.

atomic-wealth
fond-illness
summer